These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8246750)

  • 1. An experimental and clinical assay with ketoconazole in the treatment of Chagas disease.
    Brener Z; Cançado JR; Galvão LM; da Luz ZM; Filardi Lde S; Pereira ME; Santos LM; Cançado CB
    Mem Inst Oswaldo Cruz; 1993; 88(1):149-53. PubMed ID: 8246750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease.
    Araújo MS; Martins-Filho OA; Pereira ME; Brener Z
    J Antimicrob Chemother; 2000 Jun; 45(6):819-24. PubMed ID: 10837436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.
    Urbina JA; Lazardi K; Marchan E; Visbal G; Aguirre T; Piras MM; Piras R; Maldonado RA; Payares G; de Souza W
    Antimicrob Agents Chemother; 1993 Mar; 37(3):580-91. PubMed ID: 8460926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease.
    Filardi LS; Brener Z
    Trans R Soc Trop Med Hyg; 1987; 81(5):755-9. PubMed ID: 3130683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts.
    Molina J; Martins-Filho O; Brener Z; Romanha AJ; Loebenberg D; Urbina JA
    Antimicrob Agents Chemother; 2000 Jan; 44(1):150-5. PubMed ID: 10602737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
    Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
    PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketoconazole promotes parasitological cure of mice infected with Trypanosoma cruzi.
    McCabe RE; Remington JS; Araujo FG
    Trans R Soc Trop Med Hyg; 1987; 81(4):613-5. PubMed ID: 3127963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fexinidazole: a potential new drug candidate for Chagas disease.
    Bahia MT; de Andrade IM; Martins TA; do Nascimento ÁF; Diniz Lde F; Caldas IS; Talvani A; Trunz BB; Torreele E; Ribeiro I
    PLoS Negl Trop Dis; 2012; 6(11):e1870. PubMed ID: 23133682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types.
    Andrade SG; Magalhães JB; Pontes AL
    Bull World Health Organ; 1985; 63(4):721-6. PubMed ID: 3936634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts.
    Guedes PM; Urbina JA; de Lana M; Afonso LC; Veloso VM; Tafuri WL; Machado-Coelho GL; Chiari E; Bahia MT
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4286-92. PubMed ID: 15504854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
    Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
    Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of the chronic phase of the experimental infection by Trypanosoma cruzi with benzonidazole and nifurtimox].
    Andrade SG; Magalhães JB; Pontes AL
    Rev Soc Bras Med Trop; 1989; 22(3):113-8. PubMed ID: 2518608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In pursuit of drugs for American trypanosomiasis: evaluation of some "standards" in a mouse model.
    Kinnamon KE; Poon BT; Hanson WL; Waits VB
    Proc Soc Exp Biol Med; 1997 Dec; 216(3):424-8. PubMed ID: 9402149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cure of short- and long-term experimental Chagas' disease using D0870.
    Urbina JA; Payares G; Molina J; Sanoja C; Liendo A; Lazardi K; Piras MM; Piras R; Perez N; Wincker P; Ryley JF
    Science; 1996 Aug; 273(5277):969-71. PubMed ID: 8688084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time and dose-dependence evaluation of nitroheterocyclic drugs for improving efficacy following Trypanosoma cruzi infection: A pre-clinical study.
    Mazzeti AL; Diniz LF; Gonçalves KR; Nascimento AFS; Spósito PAF; Mosqueira VCF; Machado-Coelho GLL; Ribeiro I; Bahia MT
    Biochem Pharmacol; 2018 Feb; 148():213-221. PubMed ID: 29309767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergic Effect of Allopurinol in Combination with Nitroheterocyclic Compounds against Trypanosoma cruzi.
    Mazzeti AL; Diniz LF; Gonçalves KR; WonDollinger RS; Assíria T; Ribeiro I; Bahia MT
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of a novel compound, (e)-1-(4'-bromo-4-biphenylyl)-1-(4-chlorophenyl)-3-dimethylaminoprop-1-ene against Trypanosoma cruzi in mice.
    Barrett PA; Beveridge E; Bull D; Caldwell IC; Islip PJ; Neal RA; Woods NC
    Experientia; 1982 Mar; 38(3):338-9. PubMed ID: 6804255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.
    Urbina JA; Payares G; Contreras LM; Liendo A; Sanoja C; Molina J; Piras M; Piras R; Perez N; Wincker P; Loebenberg D
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1771-7. PubMed ID: 9661019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aetiological treatment with itraconazole or ketoconazole in individuals with Trypanosoma cruzi/HIV co-infection.
    de Almeida EA; Silva EL; Guariento ME; Aoki FH; Pedro Rde J
    Ann Trop Med Parasitol; 2009 Sep; 103(6):471-6. PubMed ID: 19695152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.